Robotic surgery first for early-stage seminoma testicular cancer
Part of Cancer clinical trials.
This trial studies whether a robotic operation (removing cancerous lymph nodes in the back of the belly) is a good first treatment for certain early-stage testicular seminoma cases. It aims to cure cancer while avoiding or delaying other treatments, and uses follow-up plans to check results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed seminoma testicular cancer removed by orchiectomy (with clear margins)
- Your scans show lymph nodes in the back of the belly are 5 cm or smaller
- Your chest scan shows no spread to the lungs or chest
- Your case fits either a new diagnosis of stage IIA/B or a relapse after watching and waiting
- You must be planning “curative” (aiming to cure) treatment with this robotic surgery
- A surgeon says you are suitable for robotic surgery and you can follow the study visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if removing the involved lymph nodes in the abdomen (retroperitoneal lymph node dissection) is a good treatment for seminoma that has spread to a small number of lymph nodes. It may help patients avoid more chemotherapy or radiation.
This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.
This trial tests lowering the intensity of treatment (de-escalation) for Stage II seminoma, a type of testicular cancer. You may receive either a surgery to remove lymph nodes or a single round of chemotherapy (carboplatin), instead of more aggressive standard treatments, to see if it's safe and effective.
This study reviews 20 years of experience in removing lymph nodes in the abdomen (RPLND) for testicular cancer. It aims to understand the outcomes of this surgery for people who had it after chemotherapy or for early-stage cancer.
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
This trial uses a robot and a special dye (ICG) to find and remove the first lymph node that might contain cancer cells in men with testicular cancer. It aims to reduce unnecessary lymph node removal while still detecting spread.
Hear when a new Lymphadenopathy Retroperitoneal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.